These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 30782299)

  • 21. Effect of phosphatase and tensin homology deleted on chromosome 10 (PTEN) gene transfection on reversal of multidrug resistance in K562/ADM cells.
    Cheng Z; Yang N; Liang W; Yan X; Li L; Pan L
    Leuk Lymphoma; 2012 Jul; 53(7):1383-9. PubMed ID: 22185283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reversal of p-glycoprotein-mediated multidrug resistance by macrocyclic bisbibenzyl derivatives in adriamycin-resistant human myelogenous leukemia (K562/A02) cells.
    Li X; Sun B; Zhu CJ; Yuan HQ; Shi YQ; Gao J; Li SJ; Lou HX
    Toxicol In Vitro; 2009 Feb; 23(1):29-36. PubMed ID: 18938236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of magnetic nanoparticles of Fe3O4 and 5-bromotetrandrine on reversal of multidrug resistance in K562/A02 leukemic cells.
    Cheng J; Wu W; Chen BA; Gao F; Xu W; Gao C; Ding J; Sun Y; Song H; Bao W; Sun X; Xu C; Chen W; Chen N; Liu L; Xia G; Li X; Wang X
    Int J Nanomedicine; 2009; 4():209-16. PubMed ID: 19918367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design, synthesis and antineoplastic activity of novel hybrids of podophyllotoxin and indirubin against human leukaemia cancer cells as multifunctional anti-MDR agents.
    Wang J; Long L; Chen Y; Xu Y; Zhang L
    Bioorg Med Chem Lett; 2018 Jun; 28(10):1817-1824. PubMed ID: 29678463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CJY, an isoflavone, reverses P-glycoprotein-mediated multidrug-resistance in doxorubicin-resistant human myelogenous leukaemia (K562/DOX) cells.
    Ji BS; He L
    J Pharm Pharmacol; 2007 Jul; 59(7):1011-5. PubMed ID: 17637197
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Down-regulation of mitochondrial ATPase by hypermethylation mechanism in chronic myeloid leukemia is associated with multidrug resistance.
    Li RJ; Zhang GS; Chen YH; Zhu JF; Lu QJ; Gong FJ; Kuang WY
    Ann Oncol; 2010 Jul; 21(7):1506-1514. PubMed ID: 20038517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MEG3 is restored by schisandrin A and represses tumor growth in choriocarcinoma cells.
    Ji L; Ma L
    J Biochem Mol Toxicol; 2020 Apr; 34(4):e22455. PubMed ID: 32057180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reversal effect of arsenic sensitivity in human leukemia cell line K562 and K562/ADM using realgar transforming solution.
    Wang X; Zhang X; Xu Z; Wang Z; Yue X; Li H
    Biol Pharm Bull; 2013; 36(4):641-8. PubMed ID: 23358330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, synthesis and evaluation of a novel series of inhibitors reversing P-glycoprotein-mediated multidrug resistance.
    Ghaleb H; Li H; Kairuki M; Qiu Q; Bi X; Liu C; Liao C; Li J; Hezam K; Huang W; Qian H
    Chem Biol Drug Des; 2018 Sep; 92(3):1708-1716. PubMed ID: 29786944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reversal of P-glycoprotein-mediated multidrug resistance by CD44 antibody-targeted nanocomplexes for short hairpin RNA-encoding plasmid DNA delivery.
    Gu J; Fang X; Hao J; Sha X
    Biomaterials; 2015 Mar; 45():99-114. PubMed ID: 25662500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effects of arsenic trioxide on expressions of vascular endothelial growth factor and P-glycoprotein in multidrug resistant leukemia cell line K562/A02].
    Liang H; Zhang Y; Zhang JD; Gu J; Ma L; Wang XL; Shen WG
    Zhong Xi Yi Jie He Xue Bao; 2007 Nov; 5(6):647-50. PubMed ID: 17997939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reversal of P-glycoprotein mediated multidrug resistance in K562 cell line by a novel synthetic calmodulin inhibitor, E6.
    Zhu HJ; Wang JS; Guo QL; Jiang Y; Liu GQ
    Biol Pharm Bull; 2005 Oct; 28(10):1974-8. PubMed ID: 16204958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Schisandrin B reverses doxorubicin resistance through inhibiting P-glycoprotein and promoting proteasome-mediated degradation of survivin.
    Wang S; Wang A; Shao M; Lin L; Li P; Wang Y
    Sci Rep; 2017 Aug; 7(1):8419. PubMed ID: 28827665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reversal of p-glycoprotein-mediated multidrug resistance by CJX1, an amlodipine derivative, in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells.
    Ji BS; He L; Liu GQ
    Life Sci; 2005 Sep; 77(18):2221-32. PubMed ID: 15967469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Reversion Mechanism Study of PESV to Multidrug Resistance at Leukemia Stem Cell Level].
    Yang XD; Shi ZX; Yan LX; Liu BS; Chen HY; Yan TG; Zhang WF; Yang X; Qin HR; Liu C; Ji HX
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Jul; 36(7):867-874. PubMed ID: 30634217
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of aromatic amides with triazole-core as potent reversal agents against P-glycoprotein-mediated multidrug resistance.
    Qiu Q; Zhu J; Chen Q; Jiang Z; Xu J; Jiang X; Huang W; Liu Z; Ye J; Xu X
    Bioorg Chem; 2019 Sep; 90():103083. PubMed ID: 31255991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ethyl lucidenates A reverses P-glycoprotein mediated vincristine resistance in K562/A02 cells.
    Li P; Chen SY; Shen SX; Liu LX; Xu JH; Zhang ZQ
    Nat Prod Res; 2019 Mar; 33(5):732-735. PubMed ID: 29130339
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Icariin enhances cytotoxicity of doxorubicin in human multidrug-resistant osteosarcoma cells by inhibition of ABCB1 and down-regulation of the PI3K/Akt pathway.
    Wang Z; Yang L; Xia Y; Guo C; Kong L
    Biol Pharm Bull; 2015; 38(2):277-84. PubMed ID: 25747987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and MDR inhibitory activity evaluation of derivatives of schizandrin A.
    Liang XX; Liu GT; Chen QH; Sun H; Chen DL; Wang FP
    J Asian Nat Prod Res; 2010 Jul; 12(7):549-56. PubMed ID: 20628932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Schisandrin B: a dual inhibitor of P-glycoprotein and multidrug resistance-associated protein 1.
    Sun M; Xu X; Lu Q; Pan Q; Hu X
    Cancer Lett; 2007 Feb; 246(1-2):300-7. PubMed ID: 16621244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.